What Caught Our Eye (WCOE), March 30, 2018
What Caught Our Eye is our week-in-review blog series, where we recap the cancer policy articles, studies, and stories that caught our attention.

Affordable Care Act

“Why Some Americans Are Risking It and Skipping Health Insurance”

Via BloombergIn tiny Marion, North Carolina, the Buchanans decided that $1,800 a month was too much to pay for health insurance, and are going without it for the first time in their lives.
Read More »

“Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of Affordable Care Act”

Via JAMA OncologyWhat are the issues with health care access and affordability for cancer survivors compared with non-cancer-affected control respondents, and how did the proportion of survivors reporting these issues change over time?
Read More »


Coping With Cancer

“Without Context or Cushion, Do Online Medical Records Make Sense?”

Via Washington PostAs she herded her two young sons into bed one evening late last December, Laura Devitt flipped through her phone to check on the routine blood tests that had been performed as part of her annual physical. She logged onto the patient portal link on her electronic medical record, scanned the results and felt her stomach clench with fear.
Read More »


Cancer News

“With $150M gift, Rogels will help U-M Cancer Center Transform Cancer Research, Care”

Via University of Michigan MedicineRichard and Susan Rogel are on a mission to boost innovative cancer research and develop the next generation of cancer pioneers — and they are committing $150 million to the University of Michigan Comprehensive Cancer Center to realize that vision.
Read More »


Cancer and Drugs

“A Billionaire Couple is Pumping Money into the Drug Pricing Debate. Can They Loosen Pharma’s Grip?”

Via STAT NewsJohn Arnold is legendary for turning contrarian bets into heaps of money. The soft-spoken Texan was a whiz kid trader at Enron before its fall. He then ran his own hedge fund, specializing in energy trading. Before he turned 34, he was a billionaire.
Read More »

“Statement from FDA Commissioner Scott Gottlieb, MD, on FDA’s Efforts to Enhance the Patient Perspective and Experience in Drug Development and Review”

By Benefit-risk assessment is at the heart of what we do to ensure that Americans have access to medical products that are safe, effective and meet their needs.
Read More »


More From “What Caught Our Eye” »

Follow us on Twitter: @CancerAdvocacy